Peek S F, Semrad S D, Perkins G A
Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Equine Vet J. 2003 Jan;35(1):86-92. doi: 10.2746/042516403775467513.
Previous reports of clostridial myonecrosis have either focused on individual case reports or have been small retrospective studies reporting very high mortality rates.
The objective of this study was to describe the outcome of cases of clostridial myonecrosis submitted to 2 referral equine hospitals in the United States over a 15 year period.
A retrospective study of case material selected on the basis of positive Clostridium spp. culture or the identification of Clostridium spp. by specific fluorescent antibody testing from soft tissue wounds was performed at Cornell and Wisconsin.
37 cases of clostridial myonecrosis were documented. Twenty-seven horses survived, 8 were subjected to euthanasia and 2 died during treatment for an overall survival rate of 73%. Twenty-five cases (68%) were associated with Clostridium perfringens alone, 6 cases (16%) with Cl. septicum alone, 4 cases with mixed clostridial infections (11%), 1 case with Cl. sporogenes and 1 with an unspeciated Clostridium spp. The highest survival rate of 81% was documented for those cases from which Cl. perfringens alone was isolated. The most common antecedent condition prior to referral was colic. The myonecrotic lesion occurred within 6-72 h of a soft tissue injection in 34 cases but was associated with a wound or laceration in the remaining 3 cases. Of the 34 cases associated with recent injections, 24 were associated with i.m. injections in the cervical region, 4 in the semimembranosus/semitendinosus region, 3 in the gluteal region, 2 with perivascular leakage of drugs administered into the jugular vein and 1 case developed simultaneously in the gluteal and neck region following injections at both sites.
Clostridial myonecrosis can occur following the i.m. or inadvertent perivascular administration of a wide variety of commonly administered drugs. It is most common in the neck musculature. Aggressive treatment can be associated with survival rates of up to 81% for cases due to Cl. perfringens alone. Survival rates for other Clostridial spp. tend to be lower.
A combination of high dose i.v. antibiotic therapy and surgical fenestration/debridement is the best approach to cases of clostridial myonecrosis. With rapid diagnosis and therapeutic intervention, horses may have up to an 81% chance of survival.
此前关于梭菌性肌坏死的报告要么聚焦于个别病例报告,要么是小型回顾性研究,报告的死亡率非常高。
本研究的目的是描述在美国两家转诊马医院15年间收治的梭菌性肌坏死病例的转归情况。
在康奈尔大学和威斯康星大学对基于梭菌属阳性培养结果或通过软组织伤口特异性荧光抗体检测鉴定出梭菌属而选取的病例材料进行回顾性研究。
记录了37例梭菌性肌坏死病例。27匹马存活,8匹实施安乐死,2匹在治疗期间死亡,总体存活率为73%。25例(68%)仅与产气荚膜梭菌有关,6例(16%)仅与败血梭菌有关,4例为混合梭菌感染(11%),1例与生孢梭菌有关,1例与未分类的梭菌属有关。仅分离出产气荚膜梭菌的病例存活率最高,为81%。转诊前最常见的前驱病症是腹痛。34例肌坏死病变发生在软组织注射后6 - 72小时内,但其余3例与伤口或撕裂伤有关。在与近期注射有关的34例中,24例与颈部肌肉注射有关,4例与半膜肌/半腱肌区域注射有关,3例与臀部注射有关,2例因药物经颈静脉注射出现血管周围渗漏,1例在臀部和颈部同时注射后在这两个部位同时发病。
多种常用药物经肌肉注射或意外血管周围给药后可发生梭菌性肌坏死。最常见于颈部肌肉组织。积极治疗可使仅由产气荚膜梭菌引起的病例存活率高达81%。其他梭菌属病例的存活率往往较低。
大剂量静脉注射抗生素治疗与手术开窗/清创相结合是治疗梭菌性肌坏死病例的最佳方法。通过快速诊断和治疗干预,马匹的存活几率可达81%。